For certain leukemia patients, some welcome findings: New research confirms long remissions after treatment with the drug ibrutinib and chemotherapy. The study involved 85 patients with chronic lymphocytic leukemia (CLL). All were 65 or younger, and 46 had more aggressive, unmutated IGHV subtype of the disease. “Patients with lower-risk CLL, which is marked by mutated…  read on >  read on >

A new study confirms yet another consequence of the pandemic for children and teenagers: Eating disorders, and hospitalizations for them, rose sharply in 2020. The study of six hospitals across Canada found new diagnoses of anorexia nearly doubled during the first wave of the COVID-19 pandemic. And the rate of hospitalization among those patients was…  read on >  read on >

Older adults have a higher risk of delirium after hip and knee surgery if they’re taking anxiety, depression or insomnia drugs, researchers say. “Our findings show that different classes of medicine are riskier than others when it comes to causing delirium after surgery, and the older the patients are, the greater the risk,” said lead…  read on >  read on >

They take care of others, but many U.S. home health care workers say they’re not in good shape themselves, a new study finds. Researchers analyzed self-reported data collected from nearly 3,000 home health care workers in 38 states between 2014 and 2018 and found that more than a quarter rated their general health as fair…  read on >  read on >

“Fights off tumors and alleviates symptoms of chemotherapy,” one vape’s advertising claims, while another is touted as an “asthma remedy, ADHD remedy, and dementia treatment.” Don’t believe the hype. Despite claims that certain vaping products may alleviate health problems, there’s no proof that they do — and they may even cause health issues, the U.S.…  read on >  read on >

Children with hard-to-control asthma may get relief from adding an injectable antibody drug to their standard treatment, a clinical trial has found. The drug, called dupilumab (Dupixent), has been available for several years to treat stubborn asthma in adults and teenagers. Based on the new findings, the U.S. Food and Drug Administration recently gave it…  read on >  read on >